BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 24039759)

  • 1. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
    Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
    PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.
    Beatson R; Maurstad G; Picco G; Arulappu A; Coleman J; Wandell HH; Clausen H; Mandel U; Taylor-Papadimitriou J; Sletmoen M; Burchell JM
    PLoS One; 2015; 10(5):e0125994. PubMed ID: 25951175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucins and Truncated
    Coelho R; Marcos-Silva L; Mendes N; Pereira D; Brito C; Jacob F; Steentoft C; Mandel U; Clausen H; David L; Ricardo S
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions.
    Haugstad KE; Hadjialirezaei S; Stokke BT; Brewer CF; Gerken TA; Burchell J; Picco G; Sletmoen M
    Glycobiology; 2016 Dec; 26(12):1338-1350. PubMed ID: 27282157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization.
    Jiang Y; Wen T; Yan R; Kim SR; Stowell SR; Wang W; Wang Y; An G; Cummings RD; Ju T
    FASEB J; 2020 Sep; 34(9):11786-11801. PubMed ID: 32692906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
    Sun X; Ju T; Cummings RD
    BMC Cancer; 2018 Aug; 18(1):827. PubMed ID: 30115016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cosmc connection to the Tn antigen in cancer.
    Ju T; Aryal RP; Kudelka MR; Wang Y; Cummings RD
    Cancer Biomark; 2014 Jan; 14(1):63-81. PubMed ID: 24643043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
    Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
    J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity.
    Lavrsen K; Madsen CB; Rasch MG; Woetmann A; Ødum N; Mandel U; Clausen H; Pedersen AE; Wandall HH
    Glycoconj J; 2013 Apr; 30(3):227-36. PubMed ID: 22878593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro synthesis of mucin-type O-glycans using saccharide primers comprising GalNAc-Ser and GalNAc-Thr residues.
    Sakura R; Nagai K; Yagi Y; Takahashi Y; Ide Y; Yagi Y; Yamamoto D; Mizuno M; Sato T
    Carbohydr Res; 2022 Jan; 511():108495. PubMed ID: 35026558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cosmc is an essential chaperone for correct protein O-glycosylation.
    Wang Y; Ju T; Ding X; Xia B; Wang W; Xia L; He M; Cummings RD
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9228-33. PubMed ID: 20439703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
    Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
    Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cosmc transfection decreases malignant behavior of Tn
    Ding R; Hu X; Hu W; Du Z; Huang P; Wang M; Sheng J; Ma Y; Wang A; Luan X; Dong M; Cao Q; Zou Y; Hu T
    Aging (Albany NY); 2021 Oct; 13(19):23393-23406. PubMed ID: 34644263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors.
    Ricardo S; Marcos-Silva L; Valente C; Coelho R; Gomes R; David L
    Virchows Arch; 2016 Jun; 468(6):715-22. PubMed ID: 27003157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen.
    Mi R; Song L; Wang Y; Ding X; Zeng J; Lehoux S; Aryal RP; Wang J; Crew VK; van Die I; Chapman AB; Cummings RD; Ju T
    J Biol Chem; 2012 Nov; 287(49):41523-33. PubMed ID: 23035125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.
    Freire T; Bay S; von Mensdorff-Pouilly S; Osinaga E
    Cancer Res; 2005 Sep; 65(17):7880-7. PubMed ID: 16140958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
    Fu C; Zhao H; Wang Y; Cai H; Xiao Y; Zeng Y; Chen H
    HLA; 2016 Dec; 88(6):275-286. PubMed ID: 27679419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells.
    Napoletano C; Rughetti A; Agervig Tarp MP; Coleman J; Bennett EP; Picco G; Sale P; Denda-Nagai K; Irimura T; Mandel U; Clausen H; Frati L; Taylor-Papadimitriou J; Burchell J; Nuti M
    Cancer Res; 2007 Sep; 67(17):8358-67. PubMed ID: 17804752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
    Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
    Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.